Cyclacel Pharmaceuticals, Inc. 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Jun 1, 2017
Insider Transaction Report
Form 4
Hradsky Gregory T.
Director
Transactions
- Award
Stock Option (right to buy)
2017-05-30+2,000→ 2,000 totalExercise: $4.38From: 2018-05-30Exp: 2027-05-30→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]These options were granted to Mr. Hradsky for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.